Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-amylase 1C (AMY1C) is a calcium-binding secreted enzyme predominantly produced by the salivary glands in humans, responsible for catalyzing the hydrolysis of internal (1→4)-alpha-D-glucosidic bonds in oligosaccharides and polysaccharides, particularly starch and glycogen, leading to their breakdown into smaller sugars like maltose and glucose during the initial step of digestion in the oral cavity[1][5][7]. The AMY1 gene family exhibits copy number variation, impacting enzyme production and possible clinical associations, including metabolic traits[8]. This gene is closely related to other amylase isoenzymes found in the pancreas and has been implicated in certain diseases such as Autism Spectrum Disorder[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-amylase 1C (AMY1C).